全文获取类型
收费全文 | 921篇 |
免费 | 92篇 |
专业分类
林业 | 47篇 |
农学 | 15篇 |
93篇 | |
综合类 | 115篇 |
农作物 | 32篇 |
水产渔业 | 36篇 |
畜牧兽医 | 610篇 |
园艺 | 20篇 |
植物保护 | 45篇 |
出版年
2023年 | 22篇 |
2022年 | 9篇 |
2021年 | 20篇 |
2020年 | 31篇 |
2019年 | 27篇 |
2018年 | 28篇 |
2017年 | 18篇 |
2016年 | 26篇 |
2015年 | 29篇 |
2014年 | 39篇 |
2013年 | 39篇 |
2012年 | 51篇 |
2011年 | 56篇 |
2010年 | 29篇 |
2009年 | 39篇 |
2008年 | 35篇 |
2007年 | 40篇 |
2006年 | 32篇 |
2005年 | 25篇 |
2004年 | 27篇 |
2003年 | 24篇 |
2002年 | 36篇 |
2001年 | 17篇 |
2000年 | 16篇 |
1999年 | 13篇 |
1998年 | 11篇 |
1996年 | 10篇 |
1994年 | 11篇 |
1992年 | 11篇 |
1991年 | 13篇 |
1990年 | 11篇 |
1989年 | 8篇 |
1988年 | 6篇 |
1987年 | 10篇 |
1985年 | 13篇 |
1984年 | 10篇 |
1979年 | 6篇 |
1978年 | 5篇 |
1977年 | 8篇 |
1976年 | 8篇 |
1975年 | 7篇 |
1974年 | 7篇 |
1973年 | 12篇 |
1972年 | 11篇 |
1971年 | 7篇 |
1969年 | 5篇 |
1968年 | 5篇 |
1958年 | 5篇 |
1893年 | 5篇 |
1892年 | 5篇 |
排序方式: 共有1013条查询结果,搜索用时 62 毫秒
11.
Incidence and risk factors for neurological signs after attenuation of single congenital portosystemic shunts in 253 dogs
下载免费PDF全文
![点击此处可从《Veterinary surgery : VS》网站下载免费的PDF全文](/ch/ext_images/free.gif)
12.
Evaluation of the rostral projection of the sacral lamina as a component of degenerative lumbosacral stenosis in German shepherd dogs
下载免费PDF全文
![点击此处可从《Veterinary surgery : VS》网站下载免费的PDF全文](/ch/ext_images/free.gif)
13.
Thomas R. De Ridder Justine E. Campbell Cheryl Burke‐Schwarz David Clegg Emily L. Elliot Samuel Geller Wendy Kozak Stephen T. Pittenger Jennifer B. Pruitt Jocelyn Riehl Julie White Melissa L. Wiest Chad M. Johannes John Morton Pamela D. Jones Peter F. Schmidt Victoria Gordon Paul Reddell 《Journal of veterinary internal medicine / American College of Veterinary Internal Medicine》2021,35(1):415-429
14.
Differentiation between dogs with thrombosis and normal dogs using the overall hemostasis potential assay
下载免费PDF全文
![点击此处可从《Journal of Veterinary Emergency and Critical Care》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Anna L. Dengate BVSc BMedSc Marie‐Christine Morel‐Kopp PhD Julia A. Beatty PhD BVetMed BSc Vanessa Barrs BVSc MVetClinStud Jody A. Braddock BVSc MVetClinStud Richard K. Churcher BVSc Bethany J. Wilson BVSc PhD Christopher M. Ward BMedSc MBChB PhD 《Journal of Veterinary Emergency and Critical Care》2016,26(3):446-452
15.
Thromboelastographic assessment of the contribution of platelets and clotting proteases to the hypercoagulable state of dogs with immune‐mediated hemolytic anemia
下载免费PDF全文
![点击此处可从《Journal of Veterinary Emergency and Critical Care》网站下载免费的PDF全文](/ch/ext_images/free.gif)
16.
17.
18.
Siarkou VI Mylonakis ME Bourtzi-Hatzopoulou E Koutinas AF 《Veterinary microbiology》2007,125(3-4):304-312
The purpose of this study was to characterize, at the molecular level, the Ehrlichia canis strains involved in naturally occurring canine monocytic ehrlichiosis (CME) in Greece, and to investigate if any sequence diversity exists between the 16S rRNA genes of those involved in the mild non-myelosuppressive or the severe myelosuppressive form of CME. To this end, amplification of the ehrlichial 16S rRNA gene was attempted by nested polymerase chain reaction (PCR) assays in bone marrow (BM) aspirates from 20 dogs tentatively diagnosed as having non-myelosuppressive (n=10, group A) or myelosuppressive (n=10, group B) CME. PCR assay using E. canis-specific primers revealed that 15 BM samples, including all group A and 5 group B dogs, were positive. Using universal PCR primers, a nearly full-length 16S rRNA gene could be amplified from 13 BM samples, including 9 group A and 4 group B dogs. The 16S rDNA analysis based on secondary structure revealed that all sequences of the Greek strains were identical to each other and indicated 100% identity among some American (Venezuelan and Brazilian), European (Greek), Middle Eastern (Turkish) and Asiatic (Thailand) strains. The results of this study suggest that the E. canis strains involved in the non-myelosuppressive and myelosuppressive forms of CME in Greece share an identical 16S rRNA genotype. 相似文献
19.
Long MT Gibbs EP Mellencamp MW Zhang S Barnett DC Seino KK Beachboard SE Humphrey PP 《Equine veterinary journal》2007,39(6):486-490
REASON FOR PERFORMING STUDY: West Nile virus (WNV) infection is endemic and able to cause disease in naive hosts. It is necessary therefore to evaluate the safety of new vaccines. OBJECTIVES: To establish: 1) the safety of a modified live Flavivirus/West Nile virus (WN-FV) chimera by administration of an overdose and testing for shed of vaccine virus and spread to uninoculated sentinel horses; 2) that this vaccine did not become pathogenic once passaged in horses; and 3) vaccine safety under field conditions. METHODS: There were 3 protocols: 1) In the overdose/shed and spread study, horses were vaccinated with a 100x immunogenicity overdose of WN-FV chimera vaccine and housed with sentinel horses. 2) A reversion to virulence study, where horses were vaccinated with a 20x immunogenicity overdose of WN-FV chimera vaccine. Horses in both studies were evaluated for abnormal health conditions and samples obtained to detect virus, seroconversion and dissemination into tissues. 3) In a field safety test 919 healthy horses of various ages, breeds and sex were used. RESULTS: Vaccination did not result in site or systemic reactions in either experimental or field-injected horses. There was no shed of vaccine virus, no detection of vaccine virus into tissue and no reversion to virulence with passage. CONCLUSIONS: WN-FV chimera vaccine is safe to use in horses with no evidence of ill effects from very high doses of vaccine. There was no evidence of reversion to virulence. In addition, administration of this vaccine to several hundred horses that may have been previously exposed to WNV or WNV vaccine resulted in no untoward reactions. POTENTIAL RELEVANCE: These studies establish that this live attenuated Flavivirus chimera is safe to use for immunoprophylaxis against WNV disease in horses. 相似文献
20.
Long MT Gibbs EP Mellencamp MW Bowen RA Seino KK Zhang S Beachboard SE Humphrey PP 《Equine veterinary journal》2007,39(6):491-497
REASON FOR PERFORMING STUDY: West Nile virus (WNF) is a Flavivirus responsible for a life-threatening neurological disease in man and horses. Development of improved vaccines against Flavivirus infections is therefore important. OBJECTIVES: To establish that a single immunogenicity dose of live Flavivirus chimera (WN-FV) vaccine protects horses from the disease and it induces a protective immune response, and to determine the duration of the protective immunity. METHODS: Clinical signs were compared between vaccinated (VACC) and control (CTRL) horses after an intrathecal WNV challenge given at 10 or 28 days, or 12 months post vaccination. RESULTS: Challenge of horses in the immunogenicity study at Day 28 post vaccination resulted in severe clinical signs of WNV infection in 10/10 control (CTRL) compared to 1/20 vaccinated (VACC) horses (P<0.01). None of the VACC horses developed viraemia and minimal histopathology was noted. Duration of immunity (DPI) was established at 12 months post vaccination. Eight of 10 CTRL exhibited severe clinical signs of infection compared to 1 of 9 VACC horses (P<0.05). There was a significant reduction in the occurrence of viraemia and histopathology lesion in VACC horses relative to CTRL horses. Horses challenged at Day 10 post vaccination experienced moderate or severe clinical signs of WNV infection in 3/3 CTRL compared to 5/6 VACC horses (P<0.05). CONCLUSIONS: This novel WN-FV chimera vaccine generates a protective immune response to WNV infection in horses that is demonstrated 10 days after a single vaccination and lasts for up to one year. POTENTIAL RELEVANCE: This is the first USDA licensed equine WNV vaccine to utilise a severe challenge model that produces the same WNV disease observed under field conditions to obtain a label claim for prevention of viraemia and aid in the prevention of WNV disease and encephalitis with a duration of immunity of 12 months. 相似文献